Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02467270 |
|---|---|
| Brief Title: | Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses (OPTIC) |
| First Submitted : | June 2, 2015 |
| First Submitted that Met QC Criteria : | June 5, 2015 |
| First Posted : | June 10, 2015 (Estimate) |
| Results First Submitted : | April 14, 2021 |
| Results First Submitted that Met QC Criteria : | May 18, 2021 |
| Results First Posted : | June 14, 2021 |
| Last Update Submitted that Met QC Criteria : | February 5, 2024 |
| Last Update Posted : | February 6, 2024 |